BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33719960)

  • 1. Harnessing the Potential of Long Non-coding RNAs to Manage Metabolic Diseases.
    Bandesh K; Masih D; Bhattacharyya N; Bharadwaj D
    Curr Pharm Des; 2021; 27(35):3668-3685. PubMed ID: 33719960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets.
    Alipoor B; Nikouei S; Rezaeinejad F; Malakooti-Dehkordi SN; Sabati Z; Ghasemi H
    J Endocrinol Invest; 2021 Oct; 44(10):2015-2041. PubMed ID: 33792864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Glucose and Lipid Metabolism by Long Non-coding RNAs: Facts and Research Progress.
    Zhang TN; Wang W; Yang N; Huang XM; Liu CF
    Front Endocrinol (Lausanne); 2020; 11():457. PubMed ID: 32765426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting long non-coding RNAs in cancers: progress and prospects.
    Li CH; Chen Y
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1895-910. PubMed ID: 23748105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNAs in metabolic diseases: from bench to bedside.
    Rey F; Zuccotti GV; Carelli S
    Trends Endocrinol Metab; 2021 Oct; 32(10):747-749. PubMed ID: 34158225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FENDRR: A pivotal, cancer-related, long non-coding RNA.
    Zheng Q; Zhang Q; Yu X; He Y; Guo W
    Biomed Pharmacother; 2021 May; 137():111390. PubMed ID: 33761608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: Regulation of the cancer epigenome by long non-coding RNAs.
    Forrest ME; Khalil AM
    Cancer Lett; 2017 Oct; 407():106-112. PubMed ID: 28400335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNAs in cancer: From discovery to therapeutic targets.
    Choudhari R; Sedano MJ; Harrison AL; Subramani R; Lin KY; Ramos EI; Lakshmanaswamy R; Gadad SS
    Adv Clin Chem; 2020; 95():105-147. PubMed ID: 32122521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current advancements and future perspectives of long noncoding RNAs in lipid metabolism and signaling.
    Duan J; Huang Z; Nice EC; Xie N; Chen M; Huang C
    J Adv Res; 2023 Jun; 48():105-123. PubMed ID: 35973552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets.
    Chandra Gupta S; Nandan Tripathi Y
    Int J Cancer; 2017 May; 140(9):1955-1967. PubMed ID: 27925173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNAs: From disease code to drug role.
    Chen Y; Li Z; Chen X; Zhang S
    Acta Pharm Sin B; 2021 Feb; 11(2):340-354. PubMed ID: 33643816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA-DANCR: A valuable cancer related long non-coding RNA for human cancers.
    Thin KZ; Liu X; Feng X; Raveendran S; Tu JC
    Pathol Res Pract; 2018 Jun; 214(6):801-805. PubMed ID: 29728310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring.
    Kunej T; Obsteter J; Pogacar Z; Horvat S; Calin GA
    Crit Rev Clin Lab Sci; 2014 Dec; 51(6):344-57. PubMed ID: 25123609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNAs as an epigenetic regulator in human cancers.
    Kondo Y; Shinjo K; Katsushima K
    Cancer Sci; 2017 Oct; 108(10):1927-1933. PubMed ID: 28776911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systems biology of myasthenia gravis, integration of aberrant lncRNA and mRNA expression changes.
    Luo Z; Li Y; Liu X; Luo M; Xu L; Luo Y; Xiao B; Yang H
    BMC Med Genomics; 2015 Mar; 8():13. PubMed ID: 25889429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNAs and cancer, an overview.
    Camacho CV; Choudhari R; Gadad SS
    Steroids; 2018 May; 133():93-95. PubMed ID: 29317255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Noncoding RNAs in Diet-Induced Metabolic Diseases.
    Brandt A; Kopp F
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.